FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation T Klein, D Abgottspon, M Wittwer, S Rabbani, J Herold, X Jiang, S Kleeb, ... Journal of medicinal chemistry 53 (24), 8627-8641, 2010 | 285 | 2010 |
Potential inhibitors for novel coronavirus protease identified by virtual screening of 606 million compounds A Fischer, M Sellner, S Neranjan, M Smieško, MA Lill International journal of molecular sciences 21 (10), 3626, 2020 | 208 | 2020 |
Decision making in structure-based drug discovery: visual inspection of docking results A Fischer, M Smiesko, M Sellner, MA Lill Journal of Medicinal Chemistry 64 (5), 2489-2500, 2021 | 195 | 2021 |
VirtualToxLab—a platform for estimating the toxic potential of drugs, chemicals and natural products A Vedani, M Dobler, M Smieško Toxicology and applied pharmacology 261 (2), 142-153, 2012 | 123 | 2012 |
pKa determination by 1H NMR spectroscopy–An old methodology revisited J Bezençon, MB Wittwer, B Cutting, M Smieško, B Wagner, M Kansy, ... Journal of Pharmaceutical and Biomedical Analysis 93, 147-155, 2014 | 114 | 2014 |
OpenVirtualToxLab—a platform for generating and exchanging in silico toxicity data A Vedani, M Dobler, Z Hu, M Smieško Toxicology letters 232 (2), 519-532, 2015 | 113 | 2015 |
Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists O Schwardt, S Rabbani, M Hartmann, D Abgottspon, M Wittwer, S Kleeb, ... Bioorganic & medicinal chemistry 19 (21), 6454-6473, 2011 | 108 | 2011 |
FimH antagonists: bioisosteres to improve the in vitro and in vivo PK/PD profile S Kleeb, L Pang, K Mayer, D Eris, A Sigl, RC Preston, P Zihlmann, ... American Chemical Society, 2015 | 107 | 2015 |
AcquaAlta: a directional approach to the solvation of ligand–protein complexes G Rossato, B Ernst, A Vedani, M Smiesko Journal of chemical information and modeling 51 (8), 1867-1881, 2011 | 92 | 2011 |
Stabilization of Branched Oligosaccharides: Lewisx Benefits from a Nonconventional C–H···O Hydrogen Bond M Zierke, M Smiesko, S Rabbani, T Aeschbacher, B Cutting, FHT Allain, ... Journal of the American Chemical Society 135 (36), 13464-13472, 2013 | 91 | 2013 |
In Silico Toxicology in Drug Discovery — Concepts Based on Three-dimensional Models A Vedani, M Smiesko Alternatives to Laboratory Animals 37 (5), 477-496, 2009 | 77 | 2009 |
Abietane diterpenoids from Salvia sahendica–antiprotozoal activity and determination of their absolute configurations SN Ebrahimi, S Zimmermann, J Zaugg, M Smiesko, R Brun, M Hamburger Planta medica 29 (02), 150-156, 2013 | 75 | 2013 |
QSAR model for predicting pesticide aquatic toxicity P Mazzatorta, M Smiesko, E Lo Piparo, E Benfenati Journal of chemical information and modeling 45 (6), 1767-1774, 2005 | 65 | 2005 |
Pre‐organization of the Core Structure of E‐Selectin Antagonists D Schwizer, JT Patton, B Cutting, M Smieško, B Wagner, A Kato, ... Chemistry–A European Journal 18 (5), 1342-1351, 2012 | 57 | 2012 |
VirtualToxLab™-In silico prediction of the toxic (endocrine-disrupting) potential of drugs, chemicals and natural products. Two years and 2,000 compounds of experience: a … A Vedani, M Smiesko, M Spreafico, O Peristera, M Dobler ALTEX-Alternatives to animal experimentation 26 (3), 167-176, 2009 | 49 | 2009 |
Andrographolide-loaded nanoparticles for brain delivery: Formulation, characterisation and in vitro permeability using hCMEC/D3 cell line C Guccione, M Oufir, V Piazzini, DE Eigenmann, EA Jähne, V Zabela, ... European Journal of Pharmaceutics and Biopharmaceutics 119, 253-263, 2017 | 48 | 2017 |
In vitro blood–brain barrier permeability predictions for GABAA receptor modulating piperine analogs DE Eigenmann, C Dürig, EA Jähne, M Smieško, M Culot, F Gosselet, ... European Journal of Pharmaceutics and Biopharmaceutics 103, 118-126, 2016 | 47 | 2016 |
Validation of an immortalized human (hBMEC) in vitro blood-brain barrier model DE Eigenmann, EA Jähne, M Smieško, M Hamburger, M Oufir Analytical and bioanalytical chemistry 408, 2095-2107, 2016 | 45 | 2016 |
Sesquiterpene Lactones from Artemisia argyi: Absolute Configuration and Immunosuppressant Activity JK Reinhardt, AM Klemd, O Danton, M De Mieri, M Smieško, R Huber, ... Journal of natural products 82 (6), 1424-1433, 2019 | 42 | 2019 |
Development of an aggregation assay to screen FimH antagonists D Abgottspon, G Rölli, L Hosch, A Steinhuber, X Jiang, O Schwardt, ... Journal of microbiological methods 82 (3), 249-255, 2010 | 42 | 2010 |